11 November 08:15-09:00Umeå Biotech Incubator, Conference room "Skogen"

Welcome to a UBI House breakfast & seminar at Tvistevägen 48A, in conference room "Skogen". UBI offers breakfast from 8.15, and the seminar starts at 8.30. 

Speaker: Jonas Wahlqvist, CEO, Nordic Biomarker. 
Seminar: "Building an international business: Lessons from Nordic Biomarker's growth journey"

In this seminar, Jonas Wahlqvist, CEO of Nordic Biomarker, will share the company's journey from its early days to its current position as an international life science company. Through key milestones, strategic decisions, and the company's current direction, he will reflect on the opportunities, challenges, and lessons learned from building a successful export-oriented business.

About Nordic Biomarker

Nordic Biomarker, a UBI alumni company, is a leading European supplier of advanced reagents for coagulation analyzers. Headquartered in Umeå, the company performs all production in-house at its facilities in Umeå and Linköping, Sweden.

About the speaker

Jonas Wahlqvist brings broad strategic experience from McKinsey & Company, combined with a strong track record in leadership and entrepreneurship within digital and technology-driven businesses. After 2.5 years as Sales and Marketing Director, he was appointed CEO of Nordic Biomarker in June 2026.

Registration deadline (for breakfast): November 6. 

Participation fee: This event is sponsored by Umeå Biotech Incubator (UBI) with support from the European Union. There is no actual fee for participating. For delegates from the industry, state-aid/de-minimis will be accounted for corresponding to 50 SEK per person.

State aid & de-minimis: Umeå Biotech Incubator is obliged to account for activities they arrange, and support they provide, that are directed to specific companies or a group of companies where the receiving companies do not pay market price for the participation. The value of this support is accounted for as state-aid. 
Small amounts of State aid (‘de minimis’ aid) are exempted from State aid control, as they are deemed to have no impact on competition and trade in the internal market of the European Union (EU). De minimis aid indeed refers to small amounts of State aid to undertakings (companies) that do not have to be notified to the European Commission by the EU Member States.
The maximum amount is € 300,000 for each undertaking over 3 years.
De minimis can also be granted to large companies that are not entitled to larger sums of state-aid under Article 22. 

Read more on state-aid and de-minimis here:

© MapTiler © OpenStreetMap contributors

Organized by